Liposomal bupivacaine has been approved by the US Food and Drug Administration for local infiltration for pain relief after bunionectomy and hemorrhoidectomy.
Market Analysis and Insights: Global Exparel Market
The global Exparel market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027.
Global Exparel Scope and Market Size
The global Exparel market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Exparel market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
20ml
10ml
Segment by Application
Veterinary
Human
The Exparel market is analysed and market size information is provided by regions (countries). Segment by Application, the Exparel market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Pacira Pharmaceuticals
Summary:
Get latest Market Research Reports on Exparel. Industry analysis & Market Report on Exparel is a syndicated market report, published as Global Exparel Sales Market Report 2021. It is complete Research Study and Industry Analysis of Exparel market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.